Millions of people around the country put themselves at higher risk for contracting skin cancer each year by frequently using tanning beds. While a cancer diagnosis can be a frightening ordeal in its own right, even those who survive can find themselves facing high medical costs and elevated life insurance premiums.Read More
As with any other health-related issue, applying for life insurance with a history of an eating disorder is difficult but not impossible.Read More
The U.S. Food and Drug Administration approves Afrezza to help patients living with diabetes, which is a costly disease that can result in high life insurance premiums.Read More
The FDA recently issued a final decision regarding the reclassification of sunlamp products and tanning beds, as excessive exposure could increase risk of skin cancer.Read More
Smokers have long been aware of the serious health risks and other drawbacks, such as high life insurance premiums, that their habit can bring.
However, recent news reports are serving as a reminder that people do nothing to diminish the risks they face from smoking menthol or light cigarettes. The government has also long warned people against using pipes, cigars and smokeless tobacco products.Read More
A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study. The drug bazedoxifene packs a powerful one-two punch that not only prevents estrogen from fueling breast cancer, but also flags the estrogen receptor from destruction.Read More
The FDA is currently discussing a proposed order, regarding the labeling and reclassification of indoor tanning beds. If finalized, a new label warning minors not to use the device will be required and sunlamp products will be classified as a moderate risk factor.Read More
Life insurance is such an important investment for families to make because one never can tell when the unexpected will happen, even to people who are young and healthy.Read More
The Federal Drug Administration approved Provenge, the first prostate cancer treatment vaccine of its kind.
The vaccine does not prevent nor cure prostate cancer, but helps men with advanced prostate cancer live four months longer, reports the newspaper. More than 32 percent of men given Provenge were alive after 3 years of beginning the treatment, as opposed to 23 percent who were given the placebo, Kantoff told the newspaper. According to the American Cancer Society, 192,000 men were diagnosed with prostate cancer in 2009 and 27,000 did not survive.Read More